Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.
Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular edema associated with uveitis.
肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱,故一般不用作肾上腺皮质功能减退的替代治疗。
Faculty of Medicine Assiut University, Assiut, Egypt
University of Miami, Miami, Florida, United States
Minia University, ALMinya, Minia, Egypt
Akram Fekry Elgazzar, Damietta, Egypt
Ahmed Abdelshafy, Banhā, QA, Egypt
United Health Services Sports Medicine Department, Vestal, New York, United States
Massachusetts Eye and Ear, Boston, Massachusetts, United States
Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Department of Surgery and Anesthesiology, Diakonhjemmet Hospital, Oslo, Norge, Norway
Department of Orthopedic Surgery, Martina Hansens Hospital, Sandvika, Norway
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
Emory University Orthopaedic and Spine Center, Atlanta, Georgia, United States
12 Executive Park Drive, Atlanta, Georgia, United States
Benha University, Banhā, QA, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.